GWM Advisors LLC increased its stake in Steris Plc (NYSE:STE) by 59.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,741 shares of the medical equipment provider’s stock after purchasing an additional 2,522 shares during the quarter. GWM Advisors LLC’s holdings in Steris Plc were worth $553,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the stock. Private Harbour Investment Management & Counsel LLC lifted its holdings in Steris Plc by 0.4% in the second quarter. Private Harbour Investment Management & Counsel LLC now owns 10,424 shares of the medical equipment provider’s stock worth $850,000 after purchasing an additional 40 shares during the period. Sawtooth Solutions LLC lifted its holdings in Steris Plc by 1.3% in the second quarter. Sawtooth Solutions LLC now owns 4,232 shares of the medical equipment provider’s stock worth $345,000 after purchasing an additional 54 shares during the period. Advisor Group Inc. lifted its holdings in Steris Plc by 1.4% in the second quarter. Advisor Group Inc. now owns 6,577 shares of the medical equipment provider’s stock worth $506,000 after purchasing an additional 91 shares during the period. TD Asset Management Inc. lifted its holdings in Steris Plc by 0.9% in the second quarter. TD Asset Management Inc. now owns 23,540 shares of the medical equipment provider’s stock worth $1,919,000 after purchasing an additional 200 shares during the period. Finally, Oppenheimer Asset Management Inc. lifted its holdings in Steris Plc by 1.3% in the second quarter. Oppenheimer Asset Management Inc. now owns 19,439 shares of the medical equipment provider’s stock worth $1,585,000 after purchasing an additional 254 shares during the period. 93.33% of the stock is owned by institutional investors and hedge funds.

In other Steris Plc news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the firm’s stock in a transaction dated Wednesday, August 16th. The stock was sold at an average price of $85.69, for a total transaction of $856,900.00. Following the transaction, the chief executive officer now owns 83,270 shares in the company, valued at $7,135,406.30. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, insider Michael J. Tokich sold 12,000 shares of the firm’s stock in a transaction dated Wednesday, October 4th. The stock was sold at an average price of $89.75, for a total value of $1,077,000.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 194,086 shares of company stock worth $16,953,621. Company insiders own 2.55% of the company’s stock.

Several equities research analysts recently weighed in on the stock. BidaskClub downgraded shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Zacks Investment Research raised shares of Steris Plc from a “hold” rating to a “buy” rating and set a $101.00 price objective for the company in a report on Monday. Finally, Raymond James Financial, Inc. upped their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the stock an “outperform” rating in a report on Wednesday, August 9th. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Steris Plc has an average rating of “Buy” and a consensus target price of $89.00.

TRADEMARK VIOLATION NOTICE: This news story was published by Watch List News and is the property of of Watch List News. If you are reading this news story on another domain, it was copied illegally and republished in violation of US & international copyright and trademark legislation. The legal version of this news story can be accessed at https://www.watchlistnews.com/steris-plc-ste-shares-bought-by-gwm-advisors-llc/1628591.html.

Steris Plc (NYSE:STE) last issued its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.80 by $0.05. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The firm had revenue of $608.00 million for the quarter, compared to analysts’ expectations of $597.66 million. During the same quarter last year, the business earned $0.79 earnings per share. The company’s revenue was down 4.8% compared to the same quarter last year.

The business also recently announced a quarterly dividend, which was paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th were issued a dividend of $0.31 per share. The ex-dividend date was Friday, August 25th. This represents a $1.24 dividend on an annualized basis and a yield of 1.37%. This is a boost from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio (DPR) is 88.57%.

Steris Plc Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Institutional Ownership by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.